Biocon Limited has informed the Exchange regarding Notice of Postal Ballot

Biocon Limited has issued a postal ballot notice seeking shareholder approval for 10 agenda items. Key item is the appointment of Mr. Shreehas Pradeep Tambe as CEO & Managing Director for 5 years from April 1, 2026. Ms. Kiran Mazumdar-Shaw's remuneration as Executive Chairperson is being revised upward, capped at Rs. 21 crores per annum (with combined cap of Rs. 25 crore including Syngene). A preferential issue of up to 87,92,317 equity shares at Rs. 376.16 per share (~Rs. 330.76 crore) is proposed, to be issued in exchange for BBL (Biocon Biologics Limited) equity shares held by 127 allottees — effectively a share swap for minority stake consolidation in the unlisted subsidiary. Additionally, 7 new director appointments/re-appointments are proposed, including 6 as Independent Directors (Rekha Mehrotra Menon reappointed; Thomas Jason Roberts as Non-Executive; Rajiv Malik, Daniel Bradbury, Peter Baron Piot, Arun Suresh Chandavarkar, and Nivruti Rai as new Independent Directors). Voting closes June 7, 2026.